Japan Compassionate Use System a “Stick” for Drug Makers? Incentives to Counter Their Burden Needed

Masaaki Kuwahara, chairman of the Japan Pharmaceutical Manufacturers Association’s (JPMA) Regulatory Affairs Committee, described the so-called “ sakigake ” review system as a “carrot” and the Japanese version of the “compassionate use” system as a “stick” at a symposium held...read more